Mometasone Nasal Spray Suppliers & Bulk Manufacturers
Available Forms: Spray
Available Strengths: 50 mcg per spray
Reference Brands: Nasonex(US & EU)
Category:
ENT
Mometasone nasal spray is a corticosteroid that reduces inflammation by suppressing immune responses in the nasal passages. It alleviates allergy symptoms such as congestion, sneezing, and runny nose. Benefits include symptom relief, improved breathing, decreased nasal inflammation, and enhanced quality of life for allergy sufferers worldwide.
Mometasone Nasal Spray is available in Spray
and strengths such as 50 mcg per spray.
Sourced from GMP-certified and ISO-compliant manufacturers, this API meets
global pharmacopeia standards (USP/EP/JP as applicable). Ideal for pharmaceutical
formulation and commercial manufacturing, Mometasone Nasal Spray is supplied in
bulk quantities with complete regulatory support including DMF, COA, and MSDS.
|
Technical Specifications & Supply Details
|
| Lead Time |
7 to 60 days (depending on batch size & schedule) |
| MOQ |
As per manufacturer’s batch size |
| COA |
Available with every batch |
| Regulatory Dossier / DMF |
Available upon request |
| Export Documentation |
FSC, COA, Manufacturing License, Product Permission |
| Standards |
IP, BP, USP |
| Certifications |
WHO-GMP, EU-GMP, USFDA (as applicable) |
Mometasone Nasal Spray can be exported to over 30 countries across Asia, Africa, Europe,
and Latin America. Flexible packaging, competitive pricing, and a verified supplier
network make Pharmatradz a trusted sourcing partner for pharmaceutical companies
and contract manufacturers worldwide.
Product Description:
Mometasone nasal spray, marketed as Nasonex, is approved in the US by the FDA and in the EU via EMA for allergic rhinitis and nasal inflammation. Regulatory approval requires dossiers including clinical efficacy, safety profiles, manufacturing standards, and pharmacovigilance plans. The FDA reviews clinical trial and quality data for timely approval, while the EMA ensures regional safety compliance. For dossier preparation, regulatory pathways, and market access, visit PharmaTradz. Proper adherence supports swift approval, safe use, and global availability, enabling millions worldwide to effectively manage allergy symptoms, nasal congestion, and sinus conditions with high-quality corticosteroid formulations supported by regional regulations.
Disclaimer: By continuing to browse, you agree to the terms of use of this website and the Trade Marks displayed, in compliance with the provisions of the Trademark Act, 1999, Section 30 and 30(1) under 'Fair use.'
The Trade Mark owner has been correctly identified under the heading Manufacturer / TM Owner as required by the Act.
Back to Listing